ALPHA TEKNOVA, INC. Operating Lease, Expense
ALPHA TEKNOVA, INC. (TKNO) reported Operating Lease, Expense of $2.90 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2024-03-27
- ALPHA TEKNOVA, INC. operating lease, expense for the quarter ending 2023-12-31 was $700.00K, a 0.00% change year-over-year.
- ALPHA TEKNOVA, INC. operating lease, expense for the quarter ending 2023-09-30 was $700.00K, a 12.50% decline year-over-year.
- ALPHA TEKNOVA, INC. operating lease, expense for the quarter ending 2023-06-30 was $700.00K, a 12.50% decline year-over-year.
- ALPHA TEKNOVA, INC. operating lease, expense for the quarter ending 2023-03-31 was $800.00K, a 0.00% change year-over-year.
- ALPHA TEKNOVA, INC. operating lease, expense for fiscal 2023 was $2.90M, a 9.38% decline from fiscal 2022.
- ALPHA TEKNOVA, INC. operating lease, expense for fiscal 2022 was $3.20M.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2023-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $1.40M derived: sum of 2 quarters · filed 2024-03-27 | $2.10M derived: sum of 3 quarters · filed 2024-03-27 | $2.90M 10-K · filed 2024-03-27 |
| 2023-09-30 | $700.00K 10-Q · filed 2023-11-13 | $1.40M derived: sum of 2 quarters · filed 2023-11-13 | $2.20M 10-Q · filed 2023-11-13 | $2.90M derived: sum of 4 quarters · filed 2024-03-27 |
| 2023-06-30 | $700.00K 10-Q · filed 2023-08-11 | $1.50M 10-Q · filed 2023-08-11 | $2.20M derived: sum of 3 quarters · filed 2024-03-27 | $3.00M derived: sum of 4 quarters · filed 2024-03-27 |
| 2023-03-31 | $800.00K 10-Q · filed 2023-05-11 | $1.50M derived: sum of 2 quarters · filed 2024-03-27 | $2.30M derived: sum of 3 quarters · filed 2024-03-27 | $3.10M derived: sum of 4 quarters · filed 2024-03-27 |
| 2022-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $1.50M derived: sum of 2 quarters · filed 2024-03-27 | $2.30M derived: sum of 3 quarters · filed 2024-03-27 | $3.20M 10-K · filed 2024-03-27 |
| 2022-09-30 | $800.00K 10-Q · filed 2023-11-13 | $1.60M derived: sum of 2 quarters · filed 2023-11-13 | $2.50M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $800.00K 10-Q · filed 2023-08-11 | $1.60M 10-Q · filed 2023-08-11 | ||
| 2022-03-31 | $800.00K 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |